ARCHIVES

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988